These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23572029)

  • 1. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man.
    Waeckel L; Potier L; Richer C; Roussel R; Bouby N; Alhenc-Gelas F
    Thromb Haemost; 2013 Sep; 110(3):476-83. PubMed ID: 23572029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man.
    Potier L; Waeckel L; Fumeron F; Bodin S; Fysekidis M; Chollet C; Bellili N; Bonnet F; Gusto G; Velho G; Marre M; Alhenc-Gelas F; Roussel R; Bouby N;
    J Endocrinol; 2014 May; 221(2):297-308. PubMed ID: 24599937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
    Pizard A; Richer C; Bouby N; Picard N; Meneton P; Azizi M; Alhenc-Gelas F
    Biol Chem; 2008 Jun; 389(6):701-6. PubMed ID: 18627303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.
    Azizi M; Boutouyrie P; Bissery A; Agharazii M; Verbeke F; Stern N; Bura-Rivière A; Laurent S; Alhenc-Gelas F; Jeunemaitre X
    J Clin Invest; 2005 Mar; 115(3):780-7. PubMed ID: 15765151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse.
    Youcef G; Belaidi E; Waeckel L; Fazal L; Clemessy M; Vincent MP; Zadigue G; Richer C; Alhenc-Gelas F; Ovize M; Pizard A
    Biochem Pharmacol; 2015 Mar; 94(1):22-9. PubMed ID: 25623731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
    Waeckel L; Potier L; Chollet C; Taveau C; Bruneval P; Roussel R; Alhenc-Gelas F; Bouby N
    Endocrinology; 2012 Aug; 153(8):3886-96. PubMed ID: 22669897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption.
    Picard N; Van Abel M; Campone C; Seiler M; Bloch-Faure M; Hoenderop JG; Loffing J; Meneton P; Bindels RJ; Paillard M; Alhenc-Gelas F; Houillier P
    J Am Soc Nephrol; 2005 Dec; 16(12):3602-10. PubMed ID: 16251243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue kallikrein deficiency and renovascular hypertension in the mouse.
    Griol-Charhbili V; Sabbah L; Colucci J; Vincent MP; Baudrie V; Laude D; Elghozi JL; Bruneval P; Picard N; Meneton P; Alhenc-Gelas F; Richer C
    Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1385-91. PubMed ID: 19244588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.
    Sharma JN
    Arch Med Res; 2006 Apr; 37(3):299-306. PubMed ID: 16513476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
    Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
    Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kallikrein-kinin system, the kidney and arterial pressure].
    Alhenc-Gelas F; Baussant T; Gardes J; Corvol P
    Nephrologie; 1988; 9(1):3-7. PubMed ID: 2839786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kallikrein-kinin pathways in hypertension and diabetes.
    Sharma JN; Narayanan P
    Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication.
    Alhenc-Gelas F; Bouby N; Girolami JP
    Front Med (Lausanne); 2019; 6():136. PubMed ID: 31316987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein deficiency.
    Potier L; Waeckel L; Richer C; Roussel R; Bouby N; Alhenc-Gelas F
    Biol Chem; 2013 Mar; 394(3):329-33. PubMed ID: 23324381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.
    Griol-Charhbili V; Messadi-Laribi E; Bascands JL; Heudes D; Meneton P; Giudicelli JF; Alhenc-Gelas F; Richer C
    FASEB J; 2005 Jul; 19(9):1172-4. PubMed ID: 15860541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal (tissue) kallikrein-kinin system in the kidney and novel potential drugs for salt-sensitive hypertension.
    Katori M; Majima M
    Prog Drug Res; 2014; 69():59-109. PubMed ID: 25130040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.